PharmacovigilanceOfficial
HHS awards $47 million to 15 organisations under MAHA ELEVATE for Medicare chronic disease prevention
🇺🇸 CMS · Fri 20 Nov 2026
HHS and CMS have announced $47 million in MAHA ELEVATE awards to 15 organisations to test chronic disease prevention approaches for people covered by Medicare.
The US Department of Health and Human Services (HHS), working through the Centers for Medicare & Medicaid Services (CMS), announced on 20 November 2026 that it is making $47 million in MAHA ELEVATE awards. Fifteen organisations will receive the funding.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (CMS). AI-assisted; check the source before acting.
More Pharmacovigilance
All →
FDA early alert: Heraeus Medevio recalls vascular guidewires over hydrophilic coating clumping risk
🇺🇸 FDA MedWatch · Fri 20 Nov 2026
EMA publishes PSUSA outcome for ibuprofen medicines, concluding with a variation
🇪🇺 EMA · Fri 20 Nov 2026
EMA publishes PSUSA outcome for nationally authorised split-virion inactivated influenza vaccines, recommending a variation
🇪🇺 EMA · Fri 20 Nov 2026
CMS proposes Medicare Advantage rule to ease market entry and widen beneficiary choice
🇺🇸 CMS · Fri 20 Nov 2026
CMS issues proposed rule on 2028 Medicare Advantage and Part D changes
🇺🇸 CMS · Fri 20 Nov 2026
FDA warns Florida clinical investigator over consent failings in INSTI HIV self-test study
🇺🇸 FDA CBER · Fri 20 Nov 2026